Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ALMS
Alumis Inc.
CAPPED RATING
Alumis Inc. (ALMS) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Momentum (D). The rating has held at C for 8 weeks.
Quantitative Factor Evaluation • Updated
Overall Rating
2.4
/ 5.0
C
Value
C
Factor Score
2.4
/ 5.0
Growth
B-
Factor Score
3.0
/ 5.0
Profitability
B-
Factor Score
3.0
/ 5.0
Momentum
D
Factor Score
1.2
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-1.8
EV / EBITDA
-0.6
Rev Growth YoY
-7.7%
Gross Margin
N/M
Price Return 3M
-79.3%
Price Return 12M
-2.6%
Catalyst Signal
0.00
Market Cap
$667.3M
TTM Revenue
$7.2M
Price / Sales
92.2
ROE
-110.9%
Historical Factor Score Progression
Held C for 8 weeks
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C (2.4) | B- (3.0) | B- (3.0) | D (1.2) | C+ (2.6) | C (2.4) |
| 2026-11-10 | C (2.2) | C+ (2.7) | B- (3.0) | D+ (1.5) | C+ (2.6) | C (2.4) |
| 2026-11-03 | C (2.3) | C+ (2.7) | B- (2.9) | D (1.4) | C+ (2.7) | C (2.4) |
| 2026-10-27 | C (2.3) | C+ (2.7) | B- (2.9) | D (1.5) | C+ (2.6) | C (2.4) |
| 2026-10-20 | C (2.4) | C+ (2.7) | B- (2.9) | D+ (1.5) | C+ (2.6) | C (2.4) |
Page
1
of
4